Emerging Biotech
Drive Launch Success
Go to market more effectively with a well-orchestrated launch.
+48 %
in number of approved drugs since 2018
36 %
of drugs failed to meet market expectations in the first year
70 %
of products that miss launch expectations continue to underperform
eBook
Pre-commercial guide to launch excellence
Identify the right mix of go-to-market plans and operational capabilities in this pre-commercial roadmap for biopharmas.
“With Veeva as our trusted partner, we accelerated launch readiness and equipped new sales, medical, and marketing teams with the digital tools they need.”
Christopher Mutz
Chief Commercial Officer & Head of Rare Disease, ANI Pharmaceuticals
Tips & Insights
Product launch tips and best practices
Launch solutions
for emerging biotech
Learn why hundreds of pre-commerial companies rely on Veeva to plan and execute their launch.